Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 147

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 147
---
      3.4
    Amended and Restated Bylaws (incorporated by reference to our Current Report on Form 8-K, as Exhibit 3.1, filed on February 8, 2019)

      4.1
    Common Stock Certificate (incorporated by reference to our Registration on Form S-3 (Registration No. 333-162968), as Exhibit 4.1, filed on November 6, 2009)

      4.2
    Form of Convertible Senior Unsecured Promissory Note (included in Exhibit 10.7)

      4.3
    Amended and Restated Certificate of Designation, Preferences, and Rights of Series A Preferred Stock (incorporated by reference to our Current Report on Form 8-K, as Exhibit 3.C, filed on December 19, 2006)

      4.4*
    Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

      4.5
    Form of Pre-Funded Warrant to Purchase Common Stock (incorporated by reference to our Current Report on Form 8-K, as Exhibit 10.1, filed on August 10, 2022)

    10.1†
    Amended and Restated 1997 Employee Stock Purchase Plan (incorporated by reference to our Form S-8 Registration Statement, as Exhibit 99.2, filed on June 30, 2023)

    10.2†
    Amended and Restated 2007 Equity Incentive Plan (incorporated by reference to our Form S-8 Registration Statement, as Exhibit 99.1, filed on June 30, 2023)

    10.3†*
    Form of 2007 Equity Incentive Plan Stock Option Agreement

    10.4†*
    Form of 2007 Equity Incentive Plan Restricted Stock Unit Agreement

    10.5†*
    Form of Indemnification Agreement

    10.6*#+
    Agreement of Sublease, dated as of September 23, 2024 by and between the Company and Crown Castle USA, Inc.

    10.7#
    Note Purchase Agreement, dated as of May 24, 2021, by and among Heron Therapeutics, Inc. and funds affiliated with Baker Bros.